Litcius/Paper detail

Anti-HCV, nucleotide inhibitors, repurposing against COVID-19

Abdo A. Elfiky

2020Life Sciences746 citationsDOIOpen Access PDF

Topics & Concepts

SofosbuvirVirologyRibavirinRNA-dependent RNA polymeraseRNA polymeraseIn silicoCoronavirus disease 2019 (COVID-19)MedicineBiologyPolymerasePharmacologyVirusHepatitis C virusInfectious disease (medical specialty)DiseaseRNAGeneInternal medicineGeneticsDiverse Scientific Research StudiesCOVID-19 Clinical Research StudiesComputational Drug Discovery Methods
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19 | Litcius